Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease

Representative in vitro model systems that accurately model response to therapy and allow the identification of new targets are important for improving our treatment of prostate cancer. Here we describe molecular characterization and drug testing in a panel of 20 prostate cancer cell lines. The cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Rebecca, Liu, Moqing, Liby, Tiera, Bayani, Nora, Bucher, Elmar, Chiotti, Kami, Derrick, Daniel, Chauchereau, Anne, Heiser, Laura, Alumkal, Joshi, Feiler, Heidi, Carroll, Peter, Korkola, James E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729982/
https://www.ncbi.nlm.nih.gov/pubmed/33303959
http://dx.doi.org/10.1038/s41598-020-78798-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729982/
https://www.ncbi.nlm.nih.gov/pubmed/33303959
http://dx.doi.org/10.1038/s41598-020-78798-x

Ejemplares similares